It's listed for next year and imo dr Finger has a weak case. Worth defending against her rather than paying her the fantasy amount she thinks she was deprived of . The company had a right to pursue the medical products it believed had the best potential, and it had an obligation to all shareholders, rather than preference her profits. Go for it and win!
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program, page-4
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.010(2.27%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 43.5¢ | $15.99K | 35.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 1925 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |